Methods | Trial design: randomised controlled trial (parallel). Country principal investigators: Italy, UK, Australia. Where trial conducted: UK. Date of trial: May to July 2002. Multi‐centre: yes. Funder: multiple sources. Blinding: outcome assessor not blinded. Lost to follow‐up: 8/83 (stocking), 11/82 (control); dropouts due to low compliance or flight connection problems. | |
Participants | Inclusion criteria: low‐ to medium‐risk participants. Participants were recruited through flight shops. Exclusion criteria: high‐risk participants defined as those with previous episodes of DVT, coagulation disorders, severe obesity, limited mobility due to bone or joint problems, neoplastic disease within the previous 2 years, large varicose veins or participants taller than 190 cm and heavier than 90 kg. No. randomised: 165. No. analysed: 146. Age (years): mean 45 (stocking), 46 (control). Sex: 44 M, 31 F (stocking), 39 M, 32 F (control) ‐ based on number analysed. | |
Interventions | Stocking Group Type of stocking: below‐knee Traveno stocking with 12 to 18 mmHg of pressure at the ankle. Stockings were put on 2 to 3 hours before the flight. No. randomised: 83. No. analysed: 75. Length of flight: 11 to 12 hours. Type of seat: Economy, seat pitch 31 inches. Route and time of flight: London to Phoenix. Additional interventions: suggestions were given to participants, i.e. mild exercise, walking, drinking water and avoiding salty food and excessive baggage restricting leg motion. Control Group Type of control: no intervention No. randomised: 82 No. analysed: 71 Length of flight: 11 to 12 hours Type of seat: Economy, seat pitch 31 ins Route and time of flight: London to Phoenix Additional interventions: the same advice as the stocking group was given. |
|
Outcomes | Outcomes assessed: incidence of DVT, SVT and oedema score. DVT diagnosed by: pre‐ and post‐flight ultrasound scanning using Sonosite scanners with a 7.5 to 13 MHz, high‐resolution probe (Sonosite, Bothell, WA, USA). This was done by compressing the major veins (femoral, popliteal and tibial). Site of DVT: none developed. Site of SVT: not mentioned. Other investigations performed: oedema test (ankle circumference, volume, swelling, discomfort). Additional complications reported: increased oedema in the control group. | |
Notes | See Feedback. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Stated randomised but no further details |
Allocation concealment (selection bias) | Unclear risk | Not reported |
Blinding of participants and personnel (performance bias) All outcomes | High risk | Not possible |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Not reported, scale described but variations possible |
Incomplete outcome data (attrition bias) All outcomes | Low risk | 12% lost to follow‐up but accounted for and distributed equally between groups |
Selective reporting (reporting bias) | Low risk | All preplanned outcomes reported |
Other bias | Low risk | No evidence of other bias |